PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 46 filers reported holding PSYCHEMEDICS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $982,000 | -43.2% | 97,375 | -21.1% | 0.06% | -43.6% |
Q1 2019 | $1,730,000 | -25.1% | 123,339 | -15.3% | 0.11% | -30.8% |
Q4 2018 | $2,311,000 | -18.2% | 145,677 | -3.0% | 0.16% | -3.0% |
Q3 2018 | $2,824,000 | -12.6% | 150,171 | -10.6% | 0.16% | +3.8% |
Q2 2018 | $3,231,000 | -21.6% | 167,932 | -13.0% | 0.16% | -18.1% |
Q1 2018 | $4,123,000 | +1.9% | 193,064 | -1.9% | 0.19% | +17.0% |
Q4 2017 | $4,047,000 | +14.5% | 196,882 | +2.6% | 0.16% | +10.7% |
Q3 2017 | $3,535,000 | -44.1% | 191,822 | -24.4% | 0.15% | -46.4% |
Q2 2017 | $6,329,000 | +24.2% | 253,651 | -0.2% | 0.28% | +20.3% |
Q1 2017 | $5,095,000 | -17.0% | 254,159 | +2.2% | 0.23% | -17.2% |
Q4 2016 | $6,138,000 | -31.8% | 248,730 | -45.3% | 0.28% | -31.1% |
Q3 2016 | $9,006,000 | +47.0% | 454,421 | +1.9% | 0.40% | +46.2% |
Q2 2016 | $6,127,000 | +5.9% | 445,913 | +6.0% | 0.28% | -2.8% |
Q1 2016 | $5,785,000 | +36.1% | 420,724 | +0.3% | 0.28% | +38.3% |
Q4 2015 | $4,251,000 | +2.8% | 419,281 | +1.9% | 0.21% | +3.5% |
Q3 2015 | $4,135,000 | -23.6% | 411,446 | +12.8% | 0.20% | -19.1% |
Q2 2015 | $5,410,000 | – | 364,831 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
22NW, LP | 274,418 | $1,089,439 | 0.78% |
WEALTH EFFECTS LLC | 40,701 | $161,582 | 0.08% |
Cannell Capital | 74,794 | $296,932 | 0.07% |
SANTA MONICA PARTNERS LP | 20,000 | $79 | 0.06% |
RBF Capital, LLC | 144,231 | $572,597 | 0.04% |
WEDBUSH SECURITIES INC | 42,414 | $168 | 0.01% |
Ancora Advisors LLC | 78,373 | $311,141 | 0.01% |
Your Advocates Ltd., LLP | 1,400 | $5,558 | 0.00% |
CRAWFORD INVESTMENT COUNSEL INC | 32,098 | $127,428 | 0.00% |
Renaissance Technologies | 273,663 | $1,086 | 0.00% |